Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Matsui

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|January 30, 2009
Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient miceKazutaka Aoki, Junji Matsui, Naoto Kubota, et al.
European Journal of Pharmacology|February 4, 2014
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Richard Davenport, Stuart Stafford, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 20, 2010
A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's diseaseHiroaki Fukumoto, Hideki Takahashi, Naoki Tarui, et al.
The Journal of Biological Chemistry|May 29, 2002
Disruption of adiponectin causes insulin resistance and neointimal formationNaoto Kubota, Yasuo Terauchi, Toshimasa Yamauchi, et al.
Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|May 27, 2003
[X-ray refraction contrast imaging]Katsuhito Yamazaki, Junji Matsui, Yasushi Kagoshima, et al.
Plos One|February 28, 2019
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathwayYu Kato, Kimiyo Tabata, Takayuki Kimura, et al.
Bioorganic & Medicinal Chemistry|April 30, 2021
Discovery of a potent and selective Axl inhibitor in preclinical modelSatoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, et al.
Cancer Science|July 26, 2014
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer modelsYasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2021
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitorsSatoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, et al.
Journal of Medicinal Chemistry|October 13, 2017
Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) InhibitorsJun Fujimoto, Rei Okamoto, Naoyoshi Noguchi, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Endocrinology and Metabolism|January 30, 2009
Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient miceKazutaka Aoki, Junji Matsui, Naoto Kubota, et al.
European Journal of Pharmacology|February 4, 2014
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Richard Davenport, Stuart Stafford, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 20, 2010
A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's diseaseHiroaki Fukumoto, Hideki Takahashi, Naoki Tarui, et al.
The Journal of Biological Chemistry|May 29, 2002
Disruption of adiponectin causes insulin resistance and neointimal formationNaoto Kubota, Yasuo Terauchi, Toshimasa Yamauchi, et al.
Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|May 27, 2003
[X-ray refraction contrast imaging]Katsuhito Yamazaki, Junji Matsui, Yasushi Kagoshima, et al.
Plos One|February 28, 2019
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathwayYu Kato, Kimiyo Tabata, Takayuki Kimura, et al.
Bioorganic & Medicinal Chemistry|April 30, 2021
Discovery of a potent and selective Axl inhibitor in preclinical modelSatoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, et al.
Cancer Science|July 26, 2014
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer modelsYasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2021
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitorsSatoshi Inoue, Yoshinobu Yamane, Shuntaro Tsukamoto, et al.
Journal of Medicinal Chemistry|October 13, 2017
Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) InhibitorsJun Fujimoto, Rei Okamoto, Naoyoshi Noguchi, et al.
Pageof 7